Quality of Life Among Survivors of Hodgkin Lymphoma
Sponsor
Memorial Sloan Kettering Cancer Center (Other)
Overall Status
Completed
CT.gov ID
NCT00598728
Collaborator
(none)
255
1
131
1.9
Study Details
Study Description
Brief Summary
The purpose of this study is to collect information on the long-term side effects of treatment for Hodgkin Lymphoma. We hope to study about 500-800 survivors of Hodgkin Lymphoma. We plan to use the findings from this study to better understand Hodgkin Lymphoma survivors' health and quality of life.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
255 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
A Global Assessment of Medical Morbidities and Quality of Life Among Survivors of Hodgkin Lymphoma
Study Start Date
:
May 1, 2005
Actual Primary Completion Date
:
Apr 1, 2016
Actual Study Completion Date
:
Apr 1, 2016
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| 1 Hodgkin lymphoma Survivors |
Behavioral: Quality of Life Questionaires
A patient questionnaire, which includes questions on medical morbidities and QOL, will be mailed to participants.
|
Outcome Measures
Primary Outcome Measures
- To evaluate the prevalence of late medical complications among HL survivors [conclusion of study]
Secondary Outcome Measures
- To study the effect of HL and its treatment on QOL among HL survivors. [conclusion of study]
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Biopsy-proven HL Participation in IRB-approved protocols for the first-line treatment of HL between 1975-2000 (IRB #75-104, #75-103, #79-17, #81-103, #90-44, #91-69).
-
English speaking
Exclusion Criteria:
- None
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Memorial Sloan-Kettering Cancer Center | New York | New York | United States | 10065 |
Sponsors and Collaborators
- Memorial Sloan Kettering Cancer Center
Investigators
- Principal Investigator: David Straus, MD, Memorial Sloan Kettering Cancer Center
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.Responsible Party:
Memorial Sloan Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT00598728
Other Study ID Numbers:
- 05-041
First Posted:
Jan 22, 2008
Last Update Posted:
Apr 27, 2016
Last Verified:
Apr 1, 2016
Keywords provided by Memorial Sloan Kettering Cancer Center
Additional relevant MeSH terms: